Global Shift Toward HPAI Vaccination Strengthens India’s Poultry Trade Outlook

As Indian regulatory authorities are finalising plans and permissions for import of Avian Influenza Vaccines specifically for protection against Highly Pathogen Avian Influenza, surprisingly the efforts seems to sit well with its exports of chicken eggs and chicken products.

Fresh evidence presented at the World Egg Organisation (WEO) Spring Assembly has reinforced confidence in the commercial viability of highly pathogenic avian influenza (HPAI) vaccination programmes, providing important policy signals for countries, including India, that are evaluating the use of vaccination to protect valuable poultry breeding stock.

Field data presented during the international meeting highlighted the performance of France’s nationwide HPAI vaccination programme in commercial duck flocks. According to the findings, vaccinated flocks maintained exceptionally high levels of protection against mortality despite experiencing one of the country’s most severe migratory bird seasons, demonstrating that well-managed vaccination programmes can significantly reduce production losses while supporting disease control.

The results are being viewed by poultry health experts as further evidence that vaccination is evolving from an emergency disease-control measure into a long-term preventive strategy for managing HPAI in regions facing persistent viral pressure.

France’s Experience Draws International Attention

France became the first major poultry-producing country to introduce large-scale preventive vaccination against HPAI in commercial duck populations after repeated outbreaks caused substantial economic losses and widespread culling.

Data presented at the WEO meeting indicated that vaccinated duck flocks remained highly protected against clinical disease and mortality throughout periods of intense viral challenge associated with migratory wild birds. The programme has significantly reduced the scale of outbreaks compared with previous epidemic seasons while allowing poultry production to continue under enhanced surveillance.

Industry delegates noted that France’s experience is providing valuable operational evidence for veterinary authorities worldwide that vaccination can be incorporated into comprehensive disease-control programmes when supported by strict monitoring and biosecurity.

International Policy Landscape Continues to Evolve

One of the most significant developments discussed during the assembly was the changing position of several poultry-importing nations toward vaccination.

Countries including Japan, Denmark, the United Kingdom and Canada are actively reviewing or developing regulatory frameworks that would permit imports from vaccinated poultry populations, provided appropriate surveillance systems are in place.

Historically, many importing countries opposed vaccination because of concerns that immunised birds could mask silent circulation of avian influenza viruses, complicating disease detection and potentially affecting international trade.

The current policy discussions suggest a gradual shift toward science-based acceptance of vaccination programmes that incorporate robust monitoring and transparent reporting.

WOAH Accelerates International Surveillance Framework

Supporting this transition, the World Organisation for Animal Health (WOAH) is coordinating development of new international guidance covering surveillance in vaccinated poultry populations.

The proposed framework, expected to be completed during 2027, will establish harmonised recommendations for monitoring vaccinated flocks while maintaining confidence in disease reporting and international trade.

Although the guidance will be non-binding, it is expected to provide countries with a globally recognised reference for designing surveillance programmes capable of demonstrating continued freedom from active infection despite the use of vaccination.

Central to these recommendations is the adoption of DIVA (Differentiating Infected from Vaccinated Animals) strategies, which combine compatible vaccines with diagnostic testing capable of distinguishing naturally infected birds from vaccinated populations.

Strategic Relevance for India

The developments are particularly relevant for India as policymakers continue evaluating options to strengthen protection of elite poultry breeding populations against HPAI.

Indian poultry experts have increasingly advocated a targeted vaccination strategy for grandparent and parent breeder flocks, recognising their critical role in maintaining national poultry genetics and production continuity.

Unlike commercial broiler flocks, breeder populations represent irreplaceable genetic resources whose loss during disease outbreaks can have long-term consequences for domestic poultry production.

Industry stakeholders have argued that any future vaccination policy should be implemented alongside comprehensive molecular surveillance, movement controls and DIVA-compatible diagnostics to preserve both disease transparency and export credibility.

Trade Considerations

International acceptance of scientifically managed vaccination programmes could significantly reduce one of the principal barriers that has historically discouraged countries from adopting preventive HPAI immunisation.

Should WOAH’s surveillance recommendations gain broad international recognition, countries implementing DIVA-based vaccination systems may be able to protect valuable poultry populations without automatically facing restrictive trade measures that have traditionally accompanied vaccination.

For India’s poultry sector, this could provide greater policy flexibility as authorities balance domestic disease prevention with ambitions to expand exports of poultry genetics, breeding stock and value-added poultry products.

Industry Perspective

The discussions at the World Egg Organisation meeting reflect a broader shift in global avian influenza management. Rather than relying exclusively on stamping-out policies and large-scale culling, veterinary authorities are increasingly considering integrated disease-control programmes that combine vaccination, surveillance, biosecurity and rapid diagnostics.

While biosecurity remains the first line of defence against HPAI, accumulating field evidence from countries such as France suggests that preventive vaccination, when supported by internationally accepted surveillance standards, may become an increasingly important component of long-term poultry health strategies.

For India, the evolving international consensus offers an opportunity to evaluate vaccination policies within a changing global regulatory environment, potentially strengthening protection of strategic breeder populations while maintaining confidence in international trade.